Results 61 to 70 of about 2,734,758 (393)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Ongoing evidence indicates increased risk of sarcopenic obesity among children and young people (CYP) with acute lymphoblastic leukemia (ALL), often beginning early in treatment, persisting into survivorship. This review evaluates current literature on body composition in CYP with ALL during and after treatment.
Lina A. Zahed +5 more
wiley +1 more source
Cannabinoids and Chronic Liver Diseases
International Journal of Molecular Sciences, 2022 Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis are the main causes of morbidity and mortality related to chronic liver diseases (CLDs) worldwide. New therapeutic approaches to prevent or reverse these liver disorders are thus emerging.
Ralph-Sydney Mboumba Bouassa +4 more
openaire +2 more sources
The Professional Medical Journal, 2018 Objectives: Objective of this study is to evaluate the frequency of pancytopeniain patients with viral chronic liver disease. Study Design: Descriptive case series study. Setting:All patients enrolled from OPD and admitted patients having a chronic liver disease either dueto HBV or HCV at Dow university hospital, Chiniot General Hospital and Zubaida ...
Ahsan Mobin +3 more
openaire +3 more sources
Advances in the concomitant chronic liver disease and colorectal cancer liver metastasis [PDF]
Waike lilun yu shijianLiver metastasis is a key factor contributing to the poor prognosis of patients with colorectal cancer (CRC), and chronic liver diseases promote the occurrence and development of CRC liver metastasis (CRLM) through various mechanisms such as altering the
YANG Yue, ZHAO Lei
doaj +1 more source
The Impact of Chronic Liver Diseases on the Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Concentrations [PDF]
, 2009 Objectives: Heart-type fatty acid binding-protein (H-FABP) has been reported to be a potential novel biochemical marker for the early diagnosis of acute myocardial infarction (AMI). The presence of H-FABP in the liver has not been reported.
Al-Hadi, Hafidh A +2 more
core +2 more sources
Endocannabinoid-related compounds in gastrointestinal diseases [PDF]
, 2018 The endocannabinoid system (ECS) is an endogenous signalling pathway involved in the control of several gastrointestinal (GI) functions at both peripheral and central levels.
Alessandra, D'Alessandro +7 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches ...
Kellee N. Parker +7 more
wiley +1 more source
Chronic liver diseases and erectile dysfunction
Frontiers in Public Health, 2023 Chronic liver diseases (CLDs) are characterized by progressive necrosis of hepatocytes, which leads to liver fibrosis and cirrhosis, and ultimately liver dysfunction.
Guanghui Zang +8 more
doaj +1 more source
Osteodystrophy in chronic liver diseases. [PDF]
, 2011 Osteoporosis and osteomalacy are, to date, among the most common metabolic disease in the world. Recently, association between metabolic bone diseases and chronic liver diseases has been increasingly reported, inducing many authors to create a new ...
ADRAGNA, Floriana +7 more
core
Liver diseases: epidemiology, causes, trends and predictions
Signal Transduction and Targeted TherapyAs a highly complex organ with digestive, endocrine, and immune-regulatory functions, the liver is pivotal in maintaining physiological homeostasis through its roles in metabolism, detoxification, and immune response.
Can Gan +9 more
semanticscholar +1 more source